Several medical device companies took hits yesterday after analysts on Wall Street downgraded their stocks, on a day when the major market indices each closed up a hair, and even medtech firms that enjoyed upgrades came under pressure. Globus Medical (NYSE:GMED) suffered the most after Morgan Stanley analyst David Lewis cut his rating on the stock from […]
Globus Medical
Globus Medical launches ExcelsiusGPS in EU
Globus Medical (NYSE:GMED) said yesterday that it launched its ExcelsiusGPS robotic guidance and navigation system in the global market, having completed installations of the system in several European countries. The ExcelsiusGPS system won CE Mark clearance in the EU in early 2017 with indications for use in both minimally invasive and open procedures for orthopedics and […]
FDA warns Globus subsidiary HBT over ViaCell production facility issues
The FDA this week released a warning letter it sent to a Globus Medical (NYSE:GMED) subsidiary Human Biologics of Texas, which produces the company’s ViaCell allograft product, over issues it found during an inspection of the facility in April. The federal watchdog noted multiple infractions during the initial inspection, and also provided a response to corrective […]
Globus Medical Q3 beats The Street
Globus Medical (NYSE:GMED) today posted third quarter earnings that handily topped expectations from analysts on Wall Street. The Audubon, Pa.-based company posted profits of $35.2 million, or 35¢ per share, on sales of $169.2 million for the three months ended September 30, for bottom-line growth of 37.6% on sales growth of 11.5% compared with the same […]
NASS 2018: Robotic platforms take center stage
Here’s a roundup from the North American Spine Society’s annual meeting in Los Angeles Medtech companies in the spinal market are rushing to join the robotic revolution, with Medtronic (NYSE:MDT) and Globus Medical (NYSE:GMED) leading the pack, according to a Leerink Partner analyst’s note from the North American Spine Society’s 2018 annual meeting. In a letter to […]
Globus Medical picks up Surgimap for ExcelsiusGPS robot-assisted surgery device
Globus Medical (NYSE:GMED) said yesterday that it acquired Nemaris and its Surgimap planning software for an undisclosed amount. Globus said it plans to integrate New York City-based the Nemaris tech into its ExcelsiusGPS robot-assisted surgery platform. “The acquisition of Surgimap bolsters Globus Medical’s efforts to advance the future of computer-assisted surgery with the goal of improving […]
Globus Medical whales on Wall Street’s Q2 expectations
Globus Medical (NYSE:GMED) today whaled on the consensus expecation with its second-quarter results and raised its outlook for the rest of the year. Audubon, Pa.-based Globus posted profits of $45.0 million, or 44¢ per share, on sales of $173.4 million for the three months ended June 30, for a bottom-line gain of 56.9% on sales growth […]
Globus Medical launches trauma devices
Globus Medical (NYSE:GMED) said today it launched the Anthem ankle fracture system and Anthem proximal humerus fracture system. The Audobon, Penn.-based company touted the release as its trauma division’s fourth and fifth product line over the past 10 months. The recently launched Anthem ankle fracture system includes seven plating options and is designed to minimize soft tissue […]
Analyst’s rating changes push Cardiovascular Systems up, NuVasive and Globus down
Ratings changes by an analyst with Bank of America-Merrill Lynch elevated one medical device company’s stock today in pre-marker trading but pushed two others down. Appearing this morning on Bloomberg television, BAML’s Bob Hopkins said Wall Street isn’t foucsed enough on the July 31 investor day at Cardiovascular Systems (NSDQ:CSII), according to Seeking Alpha. The St. Paul, […]
7 medtech stories we missed this week: June 15, 2018
From Cytosorbents opening a new U.S. manufacturing facility to DyAnsys received FDA clearance for a wearable to treat opioid withdrawals, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Cytosorbents opens new U.S. manufacturing facility CytoSorbents announced in a June 12 press release that it has opened a new […]
OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018
OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]
